akusherstvoObstetrics, Gynecology and ReproductionАкушерство, Гинекология и Репродукция2313-73472500-3194IRBIS LLC10.17749/2313-7347.2018.12.2.048-054akusherstvo-494Research ArticleREVIEW ARTICLESНАУЧНЫЕ ОБЗОРЫGestational trophoblastic disease: risk factors, current methods of diagnostics and treatmentГестационная трофобластическая болезнь: факторы риска, современные методы диагностики и леченияСолоповаА. Г.SolopovaA. G.

Солопова Антонина Григорьевна – доктор медицинских наук, профессор кафедры акушерства и гинекологии медико-профилактического факультета

109004, Москва, ул. Земляной Вал, 62, стр. 1

Solopova Antonina Grigorievna – MD, Professor, Department of Obstetrics and Gynecology, Faculty of Clinical and Preventive Medicine

62, str. 1, ul. Zemlyanoi Val, Moscow, 109004

antoninasolopova@yandex.ruМакацарияА. Д.MakatsariyaA. D.

Макацария Александр Давидович – доктор медицинских наук, член-корреспондент РАН, профессор, зав. кафедрой акушерства и гинекологии медико-профилактического факультета

109004, Москва, ул. Земляной Вал, 62, стр. 1

Makatsariya Alexander Davidovich – MD, Corresponding Member of RAS, Professor, Head of Department of Obstetrics and Gynecology, Faculty of Clinical and Preventive Medicine

62, str. 1, ul. Zemlyanoi Val, Moscow, 109004

 

gemostasis@mail.ruСолоповаА. Е.SolopovaA. Е.

Солопова Алина Евгеньевна – доктор медицинских наук, ведущий научный сотрудник отдела лучевой диагностики

117997, Москва, ул. академика Опарина, 4

Solopova Alina Evgen’evna – MD, Leading Researcher, Department of Radiology

4, ul. academika Oparina, Moscow, 117997

dr.solopova@mail.ruЕгороваЕ. С.EgorovaЕ. S.

Егорова Елена Сергеевна – кандидат медицинских наук, доцент кафедры акушерства и гинекологии медико-профилактического факультета

109004, Москва, ул. Земляной Вал, 62, стр. 1

 

Egorova Elena Sergeevna – PhD, Associate Professor, Department of Obstetrics and Gynecology, Faculty of Clinical and Preventive Medicine

62, str. 1, ul. Zemlyanoi Val, Moscow, 109004

 

eesdoctor@mail.ruМосквичёваВ. С.MoskvichyovaV. S.

Москвичёва Виктория Сергеевна – студентка 6-го курса педиатрического факультета

109004, Москва, ул. Земляной Вал, 62, стр. 1

Moskvichyova Viktoria Sergeevna – Graduate Student, Faculty of Pediatrics

62, str. 1, ul. Zemlyanoi Val, Moscow, 109004

 

viktoria@mail.ruФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University, Health Ministry of Russian FederationRussian FederationФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Министерства здравоохранения Российской ФедерацииРоссияNational Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Health Ministry of Russian FederationRussian Federation2018260820181224854Copyright © Solopova A.G., Makatsariya A.D., Solopova A.Е., Egorova Е.S., Moskvichyova V.S., 20182018Солопова А.Г., Макацария А.Д., Солопова А.Е., Егорова Е.С., Москвичёва В.С.Solopova A.G., Makatsariya A.D., Solopova A.Е., Egorova Е.S., Moskvichyova V.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gynecology.su/jour/article/view/494

The article presents current data on diagnosis and treatment of patients with gestational trophoblastic disease, risk factors and their role in pathology development are also analyzed.

В статье представлены современные методы диагностики и лечения гестационной трофобластической болезни, а также проанализированы имеющиеся данные о факторах риска и их роли в развитии этой патологии.

Гестационная трофобластическая болезньпузырный заносхорионэпителиоматрофобластическая опухоль плацентарного ложаэпителиоидная трофобластическая опухольGestational trophoblastic diseasehydatidiform molechorionepitheliomaplacental bed trophoblastic tumorepithelioid trophoblastic tumorReferencesFulop V., Mok S.C., Berkowitz R.S. Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004; 49 (6): 415-22.Fulop V., Mok S.C., Berkowitz R.S. Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004; 49 (6): 415-22.Fisher R.A., Lavery S.A., Carby A. et al. What a difference an egg makes. Lancet. 2011; 378 (9807): 1974.Fisher R.A., Lavery S.A., Carby A. et al. What a difference an egg makes. Lancet. 2011; 378 (9807): 1974.Galton V.A., Ingbar S.H., Jimenez-Fonseca J. et al. Alterations in thyroid hormone economy in patients with hydatidiform mole. J Clin Invest. 1971; 50: 1345-54.Galton V.A., Ingbar S.H., Jimenez-Fonseca J. et al. Alterations in thyroid hormone economy in patients with hydatidiform mole. J Clin Invest. 1971; 50: 1345-54.Amir S.M., Osathanondh R., Berkowitz R.S. et al. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984; 150: 723-8.Amir S.M., Osathanondh R., Berkowitz R.S. et al. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984; 150: 723-8.Osathanondh R., Berkowitz R.S., de Cholnoky C. et al. Hormonal measurements in patients with teca lutein cysts and gestational trophoblastic disease. J Reprod Med. 1986; 31: 179-83.Osathanondh R., Berkowitz R.S., de Cholnoky C. et al. Hormonal measurements in patients with teca lutein cysts and gestational trophoblastic disease. J Reprod Med. 1986; 31: 179-83.Berkowitz R.S., Goldstein D.P., Bernstein M.R. Laparoscopy in the management of gestational trophoblastic neoplasms. J Reprod Med. 1980; 24: 261-64.Berkowitz R.S., Goldstein D.P., Bernstein M.R. Laparoscopy in the management of gestational trophoblastic neoplasms. J Reprod Med. 1980; 24: 261-64.Szulman A.E., Surti U. The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol. 1982; 59 (5): 597-602.Szulman A.E., Surti U. The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol. 1982; 59 (5): 597-602.Berkowitz R.S., Goldstein D.P., Bernstein M.R. Natural history of partial molar pregnancy. Obstet Gynecol. 1985; 66 (5): 677-81.Berkowitz R.S., Goldstein D.P., Bernstein M.R. Natural history of partial molar pregnancy. Obstet Gynecol. 1985; 66 (5): 677-81.Genest D.R., Dorfman D.M., Castrillon D.H. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J Reprod Med. 2002; 47 (5): 342-6.Genest D.R., Dorfman D.M., Castrillon D.H. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J Reprod Med. 2002; 47 (5): 342-6.Hussein M.R. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles. Exp Mol Pathol. 2009; 87 (1): 63-9.Hussein M.R. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles. Exp Mol Pathol. 2009; 87 (1): 63-9.Halperin R., Peller S., Sandbank J. et al. Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta. 2000; 21 (1): 188-91.Halperin R., Peller S., Sandbank J. et al. Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta. 2000; 21 (1): 188-91.Lurain J.R. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010; 203 (6): 531-9.Lurain J.R. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010; 203 (6): 531-9.Benson C.B., Genest D.R., Bernstein M.R. et al. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000; 16: 188-91.Benson C.B., Genest D.R., Bernstein M.R. et al. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000; 16: 188-91.Shaaban A.M., Rezvani M., Haroun R.R. et al. Gestational Trophoblastic Disease: Clinical and Imaging Features. Radiographics. 2017; 37 (2): 681-700.Shaaban A.M., Rezvani M., Haroun R.R. et al. Gestational Trophoblastic Disease: Clinical and Imaging Features. Radiographics. 2017; 37 (2): 681-700.Berkowitz R.S., Tuncer Z.S., Bernstein M.R., Goldstein D.P. Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol. 2000; 27 (6): 678-85.Berkowitz R.S., Tuncer Z.S., Bernstein M.R., Goldstein D.P. Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol. 2000; 27 (6): 678-85.Soper J.T. Surgical therapy for gestational trophoblastic disease. J Reprod Med. 1994; 39: 168.Soper J.T. Surgical therapy for gestational trophoblastic disease. J Reprod Med. 1994; 39: 168.Goldstein D.P., Berkowitz R.S. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995; 22: 157-60.Goldstein D.P., Berkowitz R.S. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995; 22: 157-60.Berkowitz R.S., Goldstein D.P., Marean A.R. et al. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol. 1981; 58 (4): 474-7.Berkowitz R.S., Goldstein D.P., Marean A.R. et al. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol. 1981; 58 (4): 474-7.Felmate C.M., Batorfi J., Fulop V. et al. Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation. Obstet Gynecol. 2003; 101: 732-6.Felmate C.M., Batorfi J., Fulop V. et al. Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation. Obstet Gynecol. 2003; 101: 732-6.Wolfberg A.J, Felmate C., Goldstein D.P.et al. Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol. 2004; 104: 551-4.Wolfberg A.J, Felmate C., Goldstein D.P.et al. Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol. 2004; 104: 551-4.Growdon W.B., Wolfberg A.J, Felrmate C.M. et al. Post evacuationh CG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. J Reprod Med. 2006; 51: 871-4.Growdon W.B., Wolfberg A.J, Felrmate C.M. et al. Post evacuationh CG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. J Reprod Med. 2006; 51: 871-4.Schmitt C., Doret M., Massardier J. et al. Risk of gestational trophoblastic neoplasia after hCG normalization according to hydatidiform type. Gynecol Oncol. 2013; 130: 86-9.Schmitt C., Doret M., Massardier J. et al. Risk of gestational trophoblastic neoplasia after hCG normalization according to hydatidiform type. Gynecol Oncol. 2013; 130: 86-9.Eagles N., Sebire N.J., Short D. et al. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Hum Reprod. 2015; 30: 1168-71.Eagles N., Sebire N.J., Short D. et al. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Hum Reprod. 2015; 30: 1168-71.

The authors declare that there are no conflicts of interest present.